Analysts See $0.60 EPS for CI Financial (CIX); Celgene (CELG) Shorts Decreased By 6.41%

January 14, 2018 - By reb123z

Celgene Corporation (NASDAQ:CELG) had a decrease of 6.41% in short interest. CELG’s SI was 11.51 million shares in January as released by FINRA. Its down 6.41% from 12.30M shares previously. With 5.87 million avg volume, 2 days are for Celgene Corporation (NASDAQ:CELG)’s short sellers to cover CELG’s short positions. The SI to Celgene Corporation’s float is 1.48%. The stock increased 1.36% or $1.42 during the last trading session, reaching $106. About 8.75M shares traded or 5.20% up from the average. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since January 14, 2017 and is uptrending. It has outperformed by 0.30% the S&P500.

Analysts expect CI Financial Corp (TSE:CIX) to report $0.60 EPS on February, 15.They anticipate $0.07 EPS change or 13.21% from last quarter’s $0.53 EPS. T_CIX’s profit would be $165.87 million giving it 12.10 P/E if the $0.60 EPS is correct. After having $0.55 EPS previously, CI Financial Corp’s analysts see 9.09% EPS growth. It closed at $29.05 lastly. It is down 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 33 analysts covering Celgene Corporation (NASDAQ:CELG), 18 have Buy rating, 2 Sell and 13 Hold. Therefore 55% are positive. Celgene Corporation had 124 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Cantor Fitzgerald on Monday, August 28. Cowen & Co maintained it with “Buy” rating and $15000 target in Friday, August 4 report. BMO Capital Markets maintained Celgene Corporation (NASDAQ:CELG) rating on Friday, October 27. BMO Capital Markets has “Outperform” rating and $148 target. Leerink Swann maintained the stock with “Buy” rating in Friday, October 20 report. The stock has “Buy” rating by BMO Capital Markets on Monday, January 8. The firm earned “Outperform” rating on Wednesday, August 12 by Cowen & Co. SunTrust maintained Celgene Corporation (NASDAQ:CELG) rating on Monday, January 8. SunTrust has “Buy” rating and $127.0 target. As per Thursday, July 6, the company rating was maintained by Credit Suisse. On Thursday, July 6 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Guggenheim on Monday, October 23.

Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. The company has market cap of $83.46 billion. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes , and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis, psoriasis, and ankylosing spondylitis; and ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers. It has a 24.84 P/E ratio. The companyÂ’s products also include VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and acute myeloid leukemia (AML); THALOMID to treat patients with multiple myeloma and erythema nodosum leprosum; and RITALIN and FOCALIN XR products.

Since August 2, 2017, it had 0 insider purchases, and 5 selling transactions for $6.27 million activity. 18,506 shares were sold by MARIO ERNEST, worth $2.42 million. $1.01M worth of Celgene Corporation (NASDAQ:CELG) was sold by KAPLAN GILLA. $248,498 worth of Celgene Corporation (NASDAQ:CELG) was sold by Curran Terrie. Shares for $1.29M were sold by CASEY MICHAEL D.

Investors sentiment decreased to 1.17 in Q3 2017. Its down 0.17, from 1.34 in 2017Q2. It is negative, as 44 investors sold Celgene Corporation shares while 457 reduced holdings. 133 funds opened positions while 451 raised stakes. 603.99 million shares or 0.25% more from 602.51 million shares in 2017Q2 were reported. Sands Cap Mngmt Limited Liability Corporation reported 0% in Celgene Corporation (NASDAQ:CELG). Howland Cap Mgmt Ltd Com stated it has 1.89% of its portfolio in Celgene Corporation (NASDAQ:CELG). Axa holds 0.74% in Celgene Corporation (NASDAQ:CELG) or 1.17M shares. Limited Liability stated it has 2,619 shares or 0.03% of all its holdings. Riggs Asset Managment invested in 1.18% or 17,966 shares. The Washington-based Tradewinds Mgmt Ltd Company has invested 0.02% in Celgene Corporation (NASDAQ:CELG). Northern Trust Corporation has invested 0.41% in Celgene Corporation (NASDAQ:CELG). 1832 Asset Mngmt L P holds 1.03M shares. Moreover, Schaper Benz Wise Investment Counsel Wi has 0.03% invested in Celgene Corporation (NASDAQ:CELG) for 1,390 shares. Balasa Dinverno Foltz Limited Liability Com invested in 0.09% or 4,129 shares. Dana Inv Advisors has 55,279 shares. Shamrock Asset Mngmt Ltd Liability Co, Texas-based fund reported 285 shares. Trust Company Of Oklahoma has invested 1.6% of its portfolio in Celgene Corporation (NASDAQ:CELG). Gilman Hill Asset Mngmt Ltd Liability Co invested in 6,501 shares. 45,440 were reported by Meiji Yasuda Asset Mngmt Ltd.

Among 7 analysts covering CI Financial (TSE:CIX), 3 have Buy rating, 1 Sell and 3 Hold. Therefore 43% are positive. CI Financial had 34 analyst reports since July 22, 2015 according to SRatingsIntel. As per Friday, February 17, the company rating was maintained by Scotia Capital. TD Securities maintained CI Financial Corp (TSE:CIX) rating on Friday, November 4. TD Securities has “Hold” rating and $25 target. The stock of CI Financial Corp (TSE:CIX) earned “Sector Perform” rating by Scotia Capital on Thursday, November 3. The rating was downgraded by RBC Capital Markets to “Underperform” on Monday, January 9. The company was upgraded on Friday, November 4 by Canaccord Genuity.

CI Financial Corp. is a publicly owned asset management holding company. The company has market cap of $8.03 billion. Through its subsidiaries, the firm manages separate client focused equity, fixed income, and alternative investments portfolios. It has a 15.54 P/E ratio. It also manages mutual funds, hedge funds, and fund of funds for its clients through its subsidiaries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: